Lord, Abbett & Co’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-198,158
| Closed | -$13.9M | – | 531 |
|
|
2024
Q1 | $13.9M | Sell |
198,158
-1,409,654
| -88% | -$98.8M | 0.04% | 359 |
|
|
2023
Q4 | $134M | Buy |
1,607,812
+1,006,641
| +167% | +$84M | 0.47% | 56 |
|
|
2023
Q3 | $17.7M | Sell |
601,171
-1,089,299
| -64% | -$32.1M | 0.07% | 342 |
|
|
2023
Q2 | $55.1M | Sell |
1,690,470
-616,799
| -27% | -$20.1M | 0.19% | 165 |
|
|
2023
Q1 | $81.2M | Sell |
2,307,269
-617,042
| -21% | -$21.7M | 0.29% | 99 |
|
|
2022
Q4 | $134M | Sell |
2,924,311
-834,311
| -22% | -$38.2M | 0.48% | 47 |
|
|
2022
Q3 | $182M | Buy |
3,758,622
+768,471
| +26% | +$37.2M | 0.67% | 26 |
|
|
2022
Q2 | $117M | Buy |
2,990,151
+732,147
| +32% | +$28.8M | 0.42% | 57 |
|
|
2022
Q1 | $83.1M | Buy |
2,258,004
+1,424,936
| +171% | +$52.5M | 0.22% | 129 |
|
|
2021
Q4 | $38M | Buy |
+833,068
| New | +$38M | 0.09% | 308 |
|